How it works

ERLOTBAY 50 contains the active ingredient Erlotinib. Erlotinib is a medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). Erlotinib works by blocking specific proteins (epidermal growth factor receptor or EGFR) that play a role in the growth and division of cancer cells. By inhibiting these proteins, Erlotinib helps slow down or stop the growth of cancer cells.

‍Indications

ERLOTBAY 50 is typically prescribed for the following conditions:
1. Non-small cell lung cancer (NSCLC): Erlotinib is used in the treatment of NSCLC, particularly in patients who have specific EGFR mutations.
2. Pancreatic cancer: It is used as a treatment option for advanced pancreatic cancer.

Dosage

The dosage of ERLOTBAY 50 will vary depending on the specific condition being treated, the patient's overall health, and the doctor's recommendations.
It is typically taken orally, usually once daily.
Follow your healthcare provider's instructions regarding the dosage and duration of treatment.

Side Effects

ERLOTBAY 50 may cause side effects in some individuals. Common side effects may include:
1. Skin rash
2. Diarrhea
3. Nausea
4. Fatigue
5. Loss of appetite
6. Mouth sores
7. Dry skin
8. Itching

Contraindication

ERLOTBAY 50 should not be used in certain situations, including:
1. Hypersensitivity or allergy to Erlotinib or any other components of the medication.
2. It should not be used in pregnant women, as it can harm the unborn baby.